Scientists in Manchester have identified a way to potentially predict which patients with an early form of breast cancer will experience disease progression.
Apr 15, 2015
Measurement of circulating tumor DNA (ctDNA) in blood can be used to detect disease recurrence in patients with a curable form of cancer known as diffuse large B-cell lymphoma (DLBCL). In most patients, measurement of ctDNA ...
Apr 03, 2015